Organika Health Products Inc. SAMe 400 mg Capsules
Organika Health Products Inc. SAMe 400 mg Capsules, NPN 80046404: natural health product licensed in Canada. Medicinal ingredients: S-(5'-Desoxyadenosin-5'-yl)-l-methionine.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| S-(5'-Desoxyadenosin-5'-yl)-l-methionine Source : S-Adenosyl-L-methionine disulfate tosylate | 400 mg | Not calculated |
Non-medicinal ingredients
Gomme de gellane, Hypromellose, Brown rice flour, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Helps relieve the symptoms and pain of osteoarthritis. Helps support healthy liver function. Helps support a healthy mood balance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult a health care practitioner if you are taking anti-depressants, hepatotoxic drugs or any other prescription medication. Consult a health care practitioner prior to use if you have cardiovascular disease. Consult your health care practitioner if symptoms persist or worsen.
Product record
- Other names
- Organika Health Products Inc. SAMe 400 mg Delayed Release Capsules, Organika Professional Line SAMe 400 mg Capsules, Organika Professional Line SAMe 400 mg Delayed Release Capsules
- Licence holder
- Organika Health Products Inc.
- NPN or DIN-HM
- 80046404
- Status
- Active licence
- Licence date
- 22 November 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80046404
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Organika Health Products Inc. SAMe 400 mg Capsules: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80046404-organika-health-products-inc-same-400-mg-capsules, updated 22 November 2013.